PureCycle Stock Rises on Bullish Thesis, Regulatory Catalysts
Analysts see 25–50% upside for PCT as regulatory approvals and plant utilization near, despite near-term execution risks. PureCycle Technologies (PCT) shares traded at $12.39 on May 29, reflecting a 70% decline from peaks and 40% short interest. The company reported $3 mil